Comerica Bank’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$33.3K Hold
594
﹤0.01% 2978
2025
Q3
$28.5K Buy
594
+144
+32% +$6.44K ﹤0.01% 3016
2025
Q2
$18.3K Hold
450
﹤0.01% 3073
2025
Q1
$19.7K Hold
450
﹤0.01% 3024
2024
Q4
$19.3K Hold
450
﹤0.01% 3039
2024
Q3
$20K Hold
450
﹤0.01% 3036
2024
Q2
$17.9K Hold
450
﹤0.01% 3022
2024
Q1
$19.4K Hold
450
﹤0.01% 3033
2023
Q4
$18.7K Hold
450
﹤0.01% 2981
2023
Q3
$17.9K Buy
+450
New +$19K ﹤0.01% 3029

Other funds holding XPH

Comerica Bank's XPH Position: Q4 2025 in Review

Comerica Bank held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q4 2025 at 594 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2978.

Comerica Bank first reported a position in XPH in Q3 2023 and has held it in 10 quarters since. 78 funds tracked by Wall St. Rank hold XPH as of Q4 2025.

  • Comerica Bank held 594 shares of State Street SPDR S&P Pharmaceuticals ETF worth $33.3K as of Q4 2025.
  • Comerica Bank left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q4 2025.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #2978 holding.
  • Comerica Bank first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2023 and has held it in 10 quarters since.
  • 78 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.